Invention Grant
- Patent Title: Antibodies targeting Glycoprotein VI
-
Application No.: US17055528Application Date: 2019-05-15
-
Publication No.: US11542329B2Publication Date: 2023-01-03
- Inventor: Kerstin Uhland , Julia Neugebauer , Steffen Runz
- Applicant: MORPHOSYS AG
- Applicant Address: DE Planegg
- Assignee: MORPHOSYS AG
- Current Assignee: MORPHOSYS AG
- Current Assignee Address: DE Planegg
- Agency: Adriano & Associates
- Priority: EP18172736 20180516
- International Application: PCT/EP2019/062522 WO 20190515
- International Announcement: WO2019/219765 WO 20191121
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P7/02 ; A61K39/00
Abstract:
The present disclosure provides antibodies or antibody fragments specific for GPVI. In particular, it relates to antibodies or antibody fragments that have combined beneficial properties and are therefore useful for the treatment or prophylaxis of GPVI related disorders or conditions, such as for example thrombotic or vascular disorders.
Public/Granted literature
- US20210214435A1 ANTIBODIES TARGETING GLYCOPROTEIN VI Public/Granted day:2021-07-15
Information query
